
1. vaccine. 2008 mar 20;26(13):1626-37. doi: 10.1016/j.vaccine.2008.01.030. epub
2008 feb 6.

tlr ligands antigen need coencapsulated biodegradable
microsphere generation potent cytotoxic lymphocyte responses.

schlosser e(1), mueller m, fischer s, basta s, busch dh, gander b, groettrup m.

author information: 
(1)division immunology, department biology, konstanz, germany.

dendritic cells phagocytose pathogens leading maturation and
cross-presentation mhc class i. found efficiency cross-priming 
in mice vaccination biodegradable poly(d,l-lactide-co-glycolide)
microspheres (mss) enhanced ovalbumin coencapsulated together with
either cpg oligonucleotide polyi:c compared co-inoculation of
ovalbumin-bearing ms soluble separately encapsulated adjuvants. single 
immunization ms containing coencaspsulated cpg ovalbumin yielded 9%
siinfekl/h-2k(b) tetramer positive ctls, production ifn-gamma, efficient
cytolysis, protection vaccinia virus infection. taken together,
coencapsulation adjuvant antigen important paradigm the
generation potent ctl responses.

doi: 10.1016/j.vaccine.2008.01.030 
pmid: 18295941  [indexed medline]

